Does AMLODIPINE\VALSARTAN Cause Product packaging quantity issue? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product packaging quantity issue have been filed in association with AMLODIPINE\VALSARTAN. This represents 0.1% of all adverse event reports for AMLODIPINE\VALSARTAN.
5
Reports of Product packaging quantity issue with AMLODIPINE\VALSARTAN
0.1%
of all AMLODIPINE\VALSARTAN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product packaging quantity issue From AMLODIPINE\VALSARTAN?
Of the 5 reports, 1 (20.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE\VALSARTAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE\VALSARTAN Cause?
Blood pressure increased (450)
Malaise (322)
Drug ineffective (314)
Hypertension (305)
Dizziness (283)
Diabetes mellitus (251)
Death (212)
Wrong technique in product usage process (206)
Fall (197)
Headache (197)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which AMLODIPINE\VALSARTAN Alternatives Have Lower Product packaging quantity issue Risk?
AMLODIPINE\VALSARTAN vs AMMONIUM
AMLODIPINE\VALSARTAN vs AMNESTEEM
AMLODIPINE\VALSARTAN vs AMOXAPINE
AMLODIPINE\VALSARTAN vs AMOXICILLIN
AMLODIPINE\VALSARTAN vs AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE